Their going to bleed all the weak longs out before it moves. You can tell with fidelity just took 10% position - plus the stock goes up on huge volume but in weak mkt days it goes down in little volume or bleeding out the weak sellers. text book how big money buys
vin: No one is smart enough to buy low and sell high.
Based on the pattern thus far, the intrinsic value of AFFY, a very nice balance sheet, a credible colloborator, Trial results on Dialysis patients, upgrades by so many institutions to atleast 11-12 $ near term, bodes very well for the stock.
Definitely this sell off is unwarranted. Whoever has shorted right now will pay a huge price in the coming days & weeks.
Earlier Arlene was the manipulator with some hedgies.
With Orwin at the helm, the professionals have taken over!
Even in the midst of this crisis Takeda needs to expand outside of Japan and AFFY even @15, it is a FREE transaction for them!